Search Results 431-440 of 16397 for monoclonal antibody

  1. Publications - Sidna M. Tulledge-Scheitel, M.D., M.P.H. - Mayo Clinic

    Monoclonal Antibody Treatment of Breakthrough COVID-19 in Fully Vaccinated Individuals with High-Risk Comorbidities. J Infect Dis. 2022 Feb 15; 225 (4):598 ...

  2. Clinical trials - Oncology (Medical)

    Denosumab is a monoclonal antibody that is used to treat bone loss in order to reduce the risk of bone fractures in healthy people, and to reduce new bone ...

  3. Publications - John R. Henley, Ph.D., M.S. - Mayo Clinic

    Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis. Expert Opin Biol Ther. 2016 Jun; 16 (6):827-839 Epub 2016 Mar 10. View PubMed; Henle ...

  4. Future therapy for Graves' ophthalmology - Mayo Clinic

    ... antibodies predict a worse prognosis. ... Bahn says: "We treated GO fibroblasts with a high-affinity human stimulatory monoclonal antibody directed against TSH ...

  5. Chemoradiation With or Without Atezolizumab in Treating Patients With Limited Stage Small Cell Lung Cancer - Mayo Clinic

    Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the ...

  6. Advances in the treatment of Crohn's disease and ulcerative colitis - Mayo Clinic

    The anti-mucosal addressin cell adhesion molecule (MAdCAM) monoclonal antibody (renamed SHP647) was effective in ulcerative colitis but not in Crohn's disease ...

  7. Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery - Mayo Clinic

    Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

  8. Acute Myelogenous Leukemia Clinical Trials

    Monoclonal antibodies, such as nivolumab, may interfere with the ability of cancer cells to grow and spread. Midostaurin may stop the growth of cancer cells ...

  9. Mayo Clinic clinical trials in patients with tumor-induced osteomalacia

    An FGF23 monoclonal antibody (burosumab) was recently approved by the U.S. Food and Drug Administration for use in patients in whom surgical tumor resection ...

  10. Tumor Size is Defining Factor to Response from Promising Melanoma Drug - Mayo Clinic News Network

    The likely reason for this finding is that MK-3475 is a monoclonal antibody that stimulates the body's immune system response to the tumors, Dr. Joseph says ...